Zhong Ji Longevity Science Group Ltd. is actively expanding its business operations, focusing on longevity science, money lending, and financial advisory services. The Group is leveraging its cross-border, cross-sector investment platform in Hong Kong to cater to the healthcare management and investment needs of high net-worth clients in mainland China. This expansion necessitates increased cash reserves to boost profitability and growth potential. Despite a profit warning for 2024 due to marketing campaign costs and restructuring expenses, the company is strategically restructuring its operations. This includes exploring new healthcare product trading businesses while continuing to develop its longevity science offerings.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zhong Ji Longevity Science Group Ltd. published the original content used to generate this news brief on June 16, 2025, and is solely responsible for the information contained therein.